WENDY KENT: Open Payments
NPI 1902310972 · MOUNT PLEASANT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 27 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $200 |
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Eisai Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: CAPLYTA, AIRSUPRA, FARXIGA, ABILIFY MAINTENA, Kerendia, NEXLETOL, REXULTI, Leqembi.
Industry payments across MI — which companies pay providers there.
